Dr Shen-Liang Shih, MD, MSc is an expert in Oncology at Kaohsiung Medical University Chung-Ho Memorial Hospital (Taiwan). Shen-Liang Shih has authored 26 publications, the most recent in 2026. SLR score: 75 (community average: 125). How the SLR is computed.

LeadR Profile

75 ScienceLeadR Reputation 75
Network Map

Oncology

Subspecialties: Genetics - Biochemistry - Radiotherapy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Kaohsiung Medical University Chung-Ho Memorial Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 26

Citations

Citations: 238 1st author: 3 Last author: 6 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer.
PMID 41948524 — breast neoplasms, neoplasms, drug therapy, chemotherapy, adjuvant, breast, receptors, progesterone, progesterone, chemotherapy
Breast Cancer (Dove Med Press)20260
Longitudinal multiomics analysis of endocrine therapy effects and gut microbiota in breast cancer recurrence.
PMID 41526647 — estrogens, breast neoplasms, neoplasms, letrozole, drug therapy, breast, therapeutics, gastrointestinal microbiome, microbiota, chemotherapy
Commun Med (Lond)20260
Intraoperative radiation therapy (IORT) in Taiwanese breast cancer patients: factors influencing local relapse risk and disease-free survival.
PMID 41503559 — radiotherapy, disease-free survival, breast neoplasms, neoplasms, hormones, breast, therapeutics
Rep Pract Oncol Radiother20250
Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer.
PMID 41482355 — genes, triple negative breast neoplasms, breast neoplasms, pharmaceutical preparations, neoplasms, biomarkers, breast, therapeutics
Cancer Genomics Proteomics20260
Population-specific polygenic risk scores for people of Han Chinese ancestry.
PMID 41094136 — genetic risk score
Nature Top journal202510

LeadR Networks

Main global connection map